Back to top

Athersys (ATHX) Catches Eye: Stock Jumps 5.5%
November 26, 2013

Read MoreHide Full Article
Athersys, Inc. ((ATHX - Free Report) ) was a big mover last session, as the company saw its shares rise by almost 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend of the company as the stock has now gained almost 35% since Nov 12.

This biotechnology company has seen a mixed track record when it comes to estimate revisions of one increase and one decrease over the past 7 days and the Zacks Consensus Estimate has moved higher over the same time frame. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Athersys currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Some better-ranked stocks in the same sector include Heska Corporation ((HSKA - Free Report) ), Actelion Ltd. () and Cytori Therapeutics, Inc. ((CYTX - Free Report) ). While Heska Corporation and Actelion hold a Zacks Rank #1 (Strong Buy), Cytori Therapeutics carries a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Athersys, Inc. (ATHX) - free report >>

Heska Corporation (HSKA) - free report >>

Cytori Therapeutics Inc (CYTX) - free report >>

More from Zacks Tale of the Tape

You May Like